Literature DB >> 26194149

Risk of Sjögren's syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case-control study.

Ming-Chi Lu1,2, Min-Chih Hsieh2,3, Malcolm Koo4,5, Ning-Sheng Lai6,7.   

Abstract

Primary Sjögren's syndrome (pSS) is a progressive systemic autoimmune disorder with a strong female predominance. Hormonal influences are thought to play a role in the development of pSS. However, no studies have specifically evaluated the association between irregular menstrual cycles and pSS. Therefore, using a health claims database, this study investigated the risk of pSS in women with irregular menstrual cycles. We conducted a case-control study using the Taiwan's National Health Insurance Research Database. A total of 360 patients diagnosed with pSS (International Classification of Diseases, ninth revision, clinical modification, ICD-9-CM code 710.2) between 2001 and 2012 were identified. Controls were frequency-matched at a rate of 5:1 to the cases by five-year age interval and index year. Both cases and controls were retrospectively traced back until 2001 for the diagnosis of irregular menstrual cycles (ICD-9-CM code 626.4). The risk of pSS was assessed using multivariate logistic regression analyses. Irregular menstrual cycles were significantly associated with pSS [adjusted odds ratio, (AOR) = 1.38, p = 0.027], after adjusted for insured amount, urbanization level, and thyroid disorder. In addition, when the data were stratified by three age categories, only the patients in the age category of 45-55 years showed significant association between irregular menstrual cycles and pSS (AOR = 1.74, p = 0.005). In this nationwide, population-based case-control study, we found a significant increased risk of pSS in female patients with irregular menstrual cycles, particularly those in their mid-forties to mid-fifties.

Entities:  

Keywords:  Autoimmune diseases; Menstruation disturbances; Sicca syndrome; Sjögren’s syndrome

Mesh:

Year:  2015        PMID: 26194149     DOI: 10.1007/s00296-015-3324-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  The influence of sex and gender on the immune response.

Authors:  Sabine Oertelt-Prigione
Journal:  Autoimmun Rev       Date:  2011-12-03       Impact factor: 9.754

Review 3.  Sex steroids in Sjögren's syndrome.

Authors:  Yrjö T Konttinen; Georg Fuellen; Yan Bing; Pauliina Porola; Vasily Stegaev; Nina Trokovic; Steffi S I Falk; Yi Liu; Peter Szodoray; Yuya Takakubo
Journal:  J Autoimmun       Date:  2012-02-01       Impact factor: 7.094

Review 4.  Gender differences in autoimmune disease.

Authors:  S T Ngo; F J Steyn; P A McCombe
Journal:  Front Neuroendocrinol       Date:  2014-05-02       Impact factor: 8.606

5.  Menstrual cycle irregularity and risk for future cardiovascular disease.

Authors:  Caren G Solomon; Frank B Hu; Andrea Dunaif; Janet E Rich-Edwards; Meir J Stampfer; Walter C Willett; Frank E Speizer; Joann E Manson
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations.

Authors:  S G Pasoto; B B Mendonça; E Bonfá
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 7.  Sjögren's syndrome: an update on epidemiology and current insights on pathophysiology.

Authors:  Tove R Reksten; Malin V Jonsson
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-02       Impact factor: 2.802

Review 8.  The influence of sex steroids on Sjögren's syndrome.

Authors:  Pauliina Porola; Mikael Laine; Liisa Virkki; Praseet Poduval; Yrjö T Konttinen
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

9.  Obstetric and gynaecological profile in patients with primary Sjögren's syndrome.

Authors:  F N Skopouli; S Papanikolaou; V Malamou-Mitsi; N Papanikolaou; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

10.  Ovarian function and disease activity in patients with systemic lupus erythematosus.

Authors:  S S Shabanova; L P Ananieva; Z S Alekberova; I I Guzov
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

View more
  2 in total

1.  Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study.

Authors:  Jeffrey J VanWormer; Christie M Bartels; Sara S McCoy; Scott Hetzel
Journal:  Clin Rheumatol       Date:  2022-06-15       Impact factor: 3.650

2.  Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren Syndrome.

Authors:  Nishant Gupta; Kathryn A Wikenheiser-Brokamp; Aryeh Fischer; Francis X McCormack
Journal:  Ann Am Thorac Soc       Date:  2016-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.